Faculty profile

Julien Van Grevenynghe

ResearcherINRS-Institut Armand-Frappier (Laval)Institut national de la recherche scientifique

This profile is built from public research funding records (CIHR, NSERC and SSHRC) and PubMed. We have not imported them from a Institut national de la recherche scientifique directory, so their courses may be missing. Find their university profile.

Julien Van Grevenynghe

Researcher

INRS-Institut Armand-Frappier (Laval)

Health Sciences

Institut national de la recherche scientifique

Quebec City, Quebec, Canada

Supervision signals

Has led research grants, which requires an independent research appointment. Ask their department whether they supervise graduate students.
6 publications in the last five years, latest in 2025.
Senior (last) author on 4 recent papers, a sign of leading a research group.
Principal investigator on 1 research grant (1 CIHR), most recently in 2022.

These signals come from public records, including CIHR, NSERC and SSHRC funding decisions. Ask the professor or the graduate program whether they are taking new students.

Academic metrics

Publications

Citations

h-index

Collaborators

Grants

Publications by year

Counts cover the works listed on the university profile; citation counts come from Dimensions.

Profiles and links

Search on Google Scholar

Find them onX · LinkedIn · Bluesky · YouTube

Signals and details

Research

Antiretroviral Therapy Antiviral Immunity Elite Controller Energy Metabolism Hiv-1 Inflammation Memory T-Cell Nrf2

Latest papers

Integrative Mechanistic Studies Identify Reticulon-3 as a Critical Modulator of Infectious Exosome-Driven Dengue Pathogenesis.
Viruses · 2025
Sustained inflammation during human T-lymphotropic virus type 1 infection: a wildfire contributing to disease progression.
Frontiers in medicine · 2025 · senior author
HSP60 controls mitochondrial ATP generation for optimal virus-specific IL-21-producing CD4 and cytotoxic CD8 memory T cell responses.
Communications biology · 2024 · senior author

All 16 publications

Latest funding

ACBP as a target for immunometabolic reprogramming in people living with HIV
CIHR · 2024 · Co-investigator
$738,224
The Nrf2 factor is a new contributor for metabolic plasticity in HIV-1 infection.
CIHR · 2022 · Nominated PI
$757,350

All 2 grants and awards

16 publications.

Integrative Mechanistic Studies Identify Reticulon-3 as a Critical Modulator of Infectious Exosome-Driven Dengue Pathogenesis.

Bitazar R, Asaba CN, Shegefti S, Noumi T, Van Grevenynghe J, Islam ST, Labonté P, Bukong TN

Viruses2025

DOI: 10.3390/v17091238 PMID: 41012666

Sustained inflammation during human T-lymphotropic virus type 1 infection: a wildfire contributing to disease progression.

Shegefti S, Alaei M, Ghahari N, Telittchenko R, Hanafi SB, Isnard S, Routy JP, Olagnier D, van Grevenynghe J

Frontiers in medicine2025Senior author

DOI: 10.3389/fmed.2025.1653384 PMID: 41020241

HSP60 controls mitochondrial ATP generation for optimal virus-specific IL-21-producing CD4 and cytotoxic CD8 memory T cell responses.

Ghahari N, Shegefti S, Alaei M, Amara A, Telittchenko R, Isnard S, Routy JP, Olagnier D, van Grevenynghe J

Communications biology2024Senior author

DOI: 10.1038/s42003-024-07326-8 PMID: 39709477

The TLR7/IRF-5 axis sensitizes memory CD4+ T cells to Fas-mediated apoptosis during HIV-1 infection.

Carmona-Pérez L, Dagenais-Lussier X, Mai LT, Stögerer T, Swaminathan S, Isnard S, Rice MR, Barnes BJ, Routy JP, van Grevenynghe J, Stäger S

JCI insight2023

DOI: 10.1172/jci.insight.167329 PMID: 37227774

Harnessing Autophagy to Overcome Antigen-Specific T-Cell Dysfunction: Implication for People Living with HIV-1.

Ghahari N, Telittchenko R, Loucif H, Isnard S, Routy JP, Olagnier D, van Grevenynghe J

International journal of molecular sciences2023Senior author

DOI: 10.3390/ijms241311018 PMID: 37446195

Autophagy-dependent glutaminolysis drives superior IL21 production in HIV-1-specific CD4 T cells.

Loucif H, Dagenais-Lussier X, Avizonis D, Choinière L, Beji C, Cassin L, Routy JP, Fritz JH, Olagnier D, van Grevenynghe J

Autophagy2022Senior author

DOI: 10.1080/15548627.2021.1972403 PMID: 34612140

Entry of the Varicellovirus Canid herpesvirus 1 into Madin-Darby canine kidney epithelial cells is pH-independent and occurs via a macropinocytosis-like mechanism but without increase in fluid uptake.

Eisa M, Loucif H, van Grevenynghe J, Pearson A

Cellular microbiology2021

DOI: 10.1111/cmi.13398 PMID: 34697890

Antiviral Potential of the Antimicrobial Drug Atovaquone against SARS-CoV-2 and Emerging Variants of Concern.

Carter-Timofte ME, Arulanandam R, Kurmasheva N, Fu K, Laroche G, Taha Z, van der Horst D, Cassin L, van der Sluis RM, Palermo E, Di Carlo D, Jacobs D, Maznyi G, Azad T, Singaravelu R, Ren F, Hansen AL, Idorn M, Holm CK, Jakobsen MR, van Grevenynghe J, Hiscott J, Paludan SR, Bell JC, Seguin J, Sabourin LA, Côté M, Diallo JS, Alain T, Olagnier D

ACS infectious diseases2021

DOI: 10.1021/acsinfecdis.1c00278 PMID: 34658235

Lipophagy confers a key metabolic advantage that ensures protective CD8A T-cell responses against HIV-1.

Loucif H, Dagenais-Lussier X, Beji C, Cassin L, Jrade H, Tellitchenko R, Routy JP, Olagnier D, van Grevenynghe J

Autophagy2021Senior author

DOI: 10.1080/15548627.2021.1874134 PMID: 33459125

Latest developments in tryptophan metabolism: Understanding its role in B cell immunity.

Dagenais-Lussier X, Loucif H, Beji C, Telittchenko R, Routy JP, van Grevenynghe J

Cytokine & growth factor reviews2021Senior author

DOI: 10.1016/j.cytogfr.2021.02.003 PMID: 33658144

Something wrong or missing on this profile? Suggest a correction

Julien Van Grevenynghe

Research

Latest papers

Latest funding

Integrative Mechanistic Studies Identify Reticulon-3 as a Critical Modulator of Infectious Exosome-Driven Dengue Pathogenesis.

Sustained inflammation during human T-lymphotropic virus type 1 infection: a wildfire contributing to disease progression.

HSP60 controls mitochondrial ATP generation for optimal virus-specific IL-21-producing CD4 and cytotoxic CD8 memory T cell responses.

The TLR7/IRF-5 axis sensitizes memory CD4+ T cells to Fas-mediated apoptosis during HIV-1 infection.

Harnessing Autophagy to Overcome Antigen-Specific T-Cell Dysfunction: Implication for People Living with HIV-1.

Autophagy-dependent glutaminolysis drives superior IL21 production in HIV-1-specific CD4 T cells.

Entry of the Varicellovirus Canid herpesvirus 1 into Madin-Darby canine kidney epithelial cells is pH-independent and occurs via a macropinocytosis-like mechanism but without increase in fluid uptake.

Antiviral Potential of the Antimicrobial Drug Atovaquone against SARS-CoV-2 and Emerging Variants of Concern.

Lipophagy confers a key metabolic advantage that ensures protective CD8A T-cell responses against HIV-1.

Latest developments in tryptophan metabolism: Understanding its role in B cell immunity.

ACBP as a target for immunometabolic reprogramming in people living with HIV

The Nrf2 factor is a new contributor for metabolic plasticity in HIV-1 infection.

Frequent collaborators

Jean-Pierre Routy

Jean-Pierre Routy

Jean-Simon Diallo

Alain Lamarre

Tommy Alain

Angela Pearson